• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哈萨克斯坦一项药物辅助治疗试点项目的评估:成功经验、挑战及扩大规模的机遇

Evaluation of a pilot medication-assisted therapy program in Kazakhstan: successes, challenges, and opportunities for scaleup.

作者信息

Boltaev Azizbek A, Deryabina Anna P, Kusainov Almas, Howard Andrea A

机构信息

ICAP, Mailman School of Public Health, Columbia University, New York, NY, USA.

出版信息

Adv Prev Med. 2012;2012:308793. doi: 10.1155/2012/308793. Epub 2012 Dec 10.

DOI:10.1155/2012/308793
PMID:23289082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3529415/
Abstract

Study Aims. Evaluate the quality and effectiveness of the medication-assisted therapy (MAT) pilot in Kazakhstan and review implementation context and related challenges. Methods. We performed a desk review of MAT policy and program documents and reviewed medical records at three MAT sites in Kazakhstan. MAT patients (n = 93) were interviewed to assess their perceptions of the program and its impact on their health, criminal, drug use, and HIV risk related behaviors as well as expenditures on nonprescribed psychoactive drugs. Persons injecting drugs who are not in treatment, MAT program staff, and other stakeholders were interviewed to obtain their perspectives on MAT. Results. Legislation supports introducing MAT as a standard of care for treatment of opioid dependence; however, its progress has been hampered by active opposition. Inadequate access and coverage, insufficient supply management, scarce infrastructure of narcological facilities, limited opportunities for staff development, and restrictive methadone dispensing policies compromise the quality of the intervention and limit its potential benefits. There were significant reductions in criminal, drug use, and HIV risk related behaviors in patients receiving MAT. Conclusions. The MAT pilot in Kazakhstan demonstrated its feasibility and effectiveness in the local context and is recommended for scaleup throughout the country.

摘要

研究目的。评估哈萨克斯坦药物辅助治疗(MAT)试点项目的质量和效果,并审视实施背景及相关挑战。方法。我们对MAT政策和项目文件进行了案头审查,并查阅了哈萨克斯坦三个MAT试点地点的医疗记录。对MAT患者(n = 93)进行了访谈,以评估他们对该项目的看法及其对他们的健康、犯罪、吸毒以及与艾滋病毒风险相关行为的影响,以及在非处方精神活性药物上的支出。对未接受治疗的注射吸毒者、MAT项目工作人员及其他利益相关者进行了访谈,以了解他们对MAT的看法。结果。立法支持将MAT作为阿片类药物依赖治疗的护理标准引入;然而,其进展受到了积极反对的阻碍。获取服务和覆盖范围不足、供应管理不善、麻醉学设施基础设施匮乏、工作人员发展机会有限以及美沙酮配给政策严格,损害了干预措施的质量并限制了其潜在益处。接受MAT治疗的患者在犯罪、吸毒以及与艾滋病毒风险相关行为方面有显著减少。结论。哈萨克斯坦的MAT试点项目在当地背景下证明了其可行性和有效性,建议在全国范围内扩大规模。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/3529415/f7376798a1e3/APM2012-308793.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/3529415/fb0865ea3100/APM2012-308793.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/3529415/caf35984207e/APM2012-308793.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/3529415/b4ecd1b43b13/APM2012-308793.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/3529415/1053c82ab28d/APM2012-308793.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/3529415/f89734c06c44/APM2012-308793.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/3529415/0ffc7b86f8a8/APM2012-308793.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/3529415/f7376798a1e3/APM2012-308793.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/3529415/fb0865ea3100/APM2012-308793.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/3529415/caf35984207e/APM2012-308793.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/3529415/b4ecd1b43b13/APM2012-308793.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/3529415/1053c82ab28d/APM2012-308793.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/3529415/f89734c06c44/APM2012-308793.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/3529415/0ffc7b86f8a8/APM2012-308793.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e95b/3529415/f7376798a1e3/APM2012-308793.007.jpg

相似文献

1
Evaluation of a pilot medication-assisted therapy program in Kazakhstan: successes, challenges, and opportunities for scaleup.哈萨克斯坦一项药物辅助治疗试点项目的评估:成功经验、挑战及扩大规模的机遇
Adv Prev Med. 2012;2012:308793. doi: 10.1155/2012/308793. Epub 2012 Dec 10.
2
The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.将药物辅助治疗阿片类药物成瘾与移动健康相结合的效果:一项随机临床试验的研究方案
Trials. 2016 Dec 12;17(1):592. doi: 10.1186/s13063-016-1726-1.
3
Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.刑事司法机构中与刑事司法-药物滥用治疗研究(CJ-DATS)相关的药物辅助治疗:可及性、障碍和意图。
Subst Abus. 2012;33(1):9-18. doi: 10.1080/08897077.2011.611460.
4
Cost-effectiveness of Treatments for Opioid Use Disorder.阿片类药物使用障碍治疗的成本效益。
JAMA Psychiatry. 2021 Jul 1;78(7):767-777. doi: 10.1001/jamapsychiatry.2021.0247.
5
Improving public health through access to and utilization of medication assisted treatment.通过获取和利用药物辅助治疗来改善公众健康。
Int J Environ Res Public Health. 2011 Oct;8(10):4102-17. doi: 10.3390/ijerph8104102. Epub 2011 Oct 24.
6
Online Medication Assisted Treatment Education for Court Professionals: Need, Opportunities and Challenges.在线药物辅助治疗法庭专业人员教育:需求、机遇与挑战。
Subst Use Misuse. 2021;56(10):1439-1447. doi: 10.1080/10826084.2021.1936045. Epub 2021 Jun 21.
7
Review of medication-assisted treatment for opioid use disorder.阿片类药物使用障碍的药物辅助治疗综述。
J Osteopath Med. 2022 Mar 14;122(7):367-374. doi: 10.1515/jom-2021-0163.
8
Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.系统评价针对美国阿片类药物流行的国家政策干预措施,2007-2018 年。
JAMA Netw Open. 2021 Feb 1;4(2):e2036687. doi: 10.1001/jamanetworkopen.2020.36687.
9
Advancing the implementation and sustainment of medication assisted treatment for opioid use disorders in prisons and jails.推进监狱中阿片类物质使用障碍药物辅助治疗的实施与持续开展。
Health Justice. 2019 Dec 12;7(1):19. doi: 10.1186/s40352-019-0100-2.
10
Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.扩大使用丁丙诺啡-纳洛酮进行艾滋病预防的物质使用治疗选择:艾滋病预防试验网络058
J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):554-61. doi: 10.1097/QAI.0000000000000510.

引用本文的文献

1
Scaling Up HIV Self-Testing and Linkage to Care Among Women Who Exchange Sex and/or Use Drugs in Kazakhstan.在哈萨克斯坦,扩大艾滋病毒自我检测并将其与性交易和/或吸毒妇女联系起来以获得护理。
AIDS Educ Prev. 2024 Jun;36(3):216-228. doi: 10.1521/aeap.2024.36.3.216.
2
Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan.影响哈萨克斯坦注射吸毒的 HIV 阳性人群抗逆转录病毒治疗依从性的个体、社会和结构因素。
Int J Drug Policy. 2018 Dec;62:43-50. doi: 10.1016/j.drugpo.2018.08.014. Epub 2018 Oct 22.
3
Differences by sex in associations between injection drug risks and drug crime conviction among people who inject drugs in Almaty, Kazakhstan.

本文引用的文献

1
Russia's drug policy fuels infectious disease epidemics.俄罗斯的毒品政策助长了传染病的流行。
Lancet Infect Dis. 2012 Apr;12(4):275-6. doi: 10.1016/s1473-3099(12)70072-5.
2
Methadone maintenance therapy outcomes in Iran.美沙酮维持治疗在伊朗的效果。
Subst Use Misuse. 2012 Jun;47(7):767-73. doi: 10.3109/10826084.2010.517726. Epub 2012 Mar 15.
3
The effectiveness of opioid maintenance treatment in prison settings: a systematic review.监狱环境中阿片类药物维持治疗的效果:系统评价。
在哈萨克斯坦阿拉木图,注射吸毒者中,性别差异对注射毒品风险与毒品犯罪定罪之间的关联。
Int J Drug Policy. 2018 Oct;60:96-106. doi: 10.1016/j.drugpo.2018.07.014. Epub 2018 Sep 13.
4
HIV Risks, Testing, and Treatment in the Former Soviet Union: Challenges and Future Directions in Research and Methodology.前苏联地区的艾滋病病毒风险、检测与治疗:研究及方法面临的挑战与未来方向
Cent Asian J Glob Health. 2016 Jan 4;4(2):225. doi: 10.5195/cajgh.2015.225. eCollection 2015.
5
The HIV epidemic in Eastern Europe and Central Asia.东欧和中亚的艾滋病疫情。
Curr HIV/AIDS Rep. 2014 Jun;11(2):168-76. doi: 10.1007/s11904-014-0202-3.
6
HIV risks among injecting and non-injecting female partners of men who inject drugs in Almaty, Kazakhstan: implications for HIV prevention, research, and policy.哈萨克斯坦阿拉木图注射毒品男性的注射和非注射女性伴侣中的艾滋病毒风险:对艾滋病毒预防、研究和政策的影响。
Int J Drug Policy. 2014 Nov;25(6):1195-203. doi: 10.1016/j.drugpo.2013.11.009. Epub 2013 Nov 23.
7
Drug use as a driver of HIV risks: re-emerging and emerging issues.药物使用是 HIV 风险的驱动因素:重新出现和新出现的问题。
Curr Opin HIV AIDS. 2014 Mar;9(2):150-5. doi: 10.1097/COH.0000000000000035.
8
HIV and people who use drugs in central Asia: confronting the perfect storm.中亚地区的艾滋病毒与吸毒者:应对这场完美风暴。
Drug Alcohol Depend. 2013 Nov;132 Suppl 1(0 1):S2-6. doi: 10.1016/j.drugalcdep.2013.07.020. Epub 2013 Aug 15.
9
HIV among injection drug users and their intimate partners in Almaty, Kazakhstan.哈萨克斯坦阿拉木图市注射吸毒者及其性伴侣中的 HIV 问题。
AIDS Behav. 2013 Sep;17(7):2490-500. doi: 10.1007/s10461-013-0484-2.
Addiction. 2012 Mar;107(3):501-17. doi: 10.1111/j.1360-0443.2011.03676.x.
4
Outcome of heroin-dependent adolescents presenting for opiate substitution treatment.海洛因依赖青少年接受阿片类药物替代治疗的结果。
J Subst Abuse Treat. 2012 Jan;42(1):35-44. doi: 10.1016/j.jsat.2011.07.007. Epub 2011 Sep 21.
5
Earning "take-home" privileges and long-term outcome in a methadone maintenance treatment program.美沙酮维持治疗方案中获得“带出院”权限和长期结局
J Addict Med. 2011 Jun;5(2):92-8. doi: 10.1097/ADM.0b013e3181e6ad48.
6
Measurement of self-reported HIV risk behaviors in injection drug users: comparison of standard versus timeline follow-back administration procedures.自评艾滋病病毒风险行为在注射吸毒者中的测量:标准与时间线回溯管理程序的比较。
J Subst Abuse Treat. 2010 Jan;38(1):60-5. doi: 10.1016/j.jsat.2009.06.004. Epub 2009 Aug 29.
7
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.美沙酮维持治疗与无阿片类药物替代治疗用于阿片类药物依赖的比较。
Cochrane Database Syst Rev. 2009 Jul 8;2009(3):CD002209. doi: 10.1002/14651858.CD002209.pub2.
8
Substitution treatment in Malaysia.马来西亚的替代疗法。
Lancet. 2008 Sep 27;372(9644):1149-50. doi: 10.1016/S0140-6736(08)61479-8.
9
On drug treatment and social control: Russian narcology's great leap backwards.论药物治疗与社会控制:俄罗斯毒品学的大倒退。
Harm Reduct J. 2008 Jun 24;5:23. doi: 10.1186/1477-7517-5-23.
10
Drug misuse treatment services in Scotland: predicting outcomes.苏格兰的药物滥用治疗服务:预测结果。
Int J Qual Health Care. 2008 Aug;20(4):271-6. doi: 10.1093/intqhc/mzn019. Epub 2008 May 20.